Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 14 | 0 | 0 | 14 |
Chain B, HADH2 protein | 14 | 0 | 0 | 14 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 9 | 0 | 0 | 9 |
Thymidine kinase | 0 | 2 | 0 | 2 |
thioredoxin reductase | 21 | 0 | 0 | 21 |
phosphopantetheinyl transferase | 11 | 0 | 0 | 11 |
GLS protein | 14 | 0 | 0 | 14 |
TDP1 protein | 36 | 0 | 0 | 36 |
Smad3 | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
EWS/FLI fusion protein | 23 | 0 | 0 | 23 |
arylsulfatase A | 13 | 0 | 0 | 13 |
euchromatic histone-lysine N-methyltransferase 2 | 37 | 0 | 0 | 37 |
activating transcription factor 6 | 11 | 0 | 0 | 11 |
Histone H2A.x | 10 | 0 | 0 | 10 |
Bloom syndrome protein isoform 1 | 15 | 0 | 0 | 15 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
lamin isoform A-delta10 | 28 | 0 | 0 | 28 |
Solute carrier family 22 member 1 | 0 | 16 | 0 | 23 |
ATP-binding cassette sub-family C member 3 | 0 | 30 | 0 | 30 |
Multidrug resistance-associated protein 4 | 0 | 30 | 0 | 31 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Bile salt export pump | 0 | 44 | 0 | 44 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 13 | 1 | 16 |
Cytochrome P450 2J2 | 0 | 11 | 0 | 12 |
Disintegrin and metalloproteinase domain-containing protein 17 | 4 | 0 | 0 | 4 |
Purine nucleoside phosphorylase | 0 | 0 | 3 | 3 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 5 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 31 | 0 | 31 |
Thymidine kinase | 0 | 2 | 0 | 2 |
interleukin 8 | 5 | 0 | 0 | 5 |
AR protein | 33 | 0 | 0 | 33 |
estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
progesterone receptor | 18 | 0 | 0 | 18 |
glucocorticoid receptor [Homo sapiens] | 27 | 0 | 0 | 27 |
estrogen-related nuclear receptor alpha | 26 | 0 | 0 | 26 |
estrogen nuclear receptor alpha | 37 | 0 | 0 | 37 |
IDH1 | 9 | 0 | 0 | 9 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 29 | 0 | 0 | 29 |
ras-related protein Rab-9A | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 26 | 0 | 0 | 26 |
geminin | 30 | 0 | 0 | 30 |
survival motor neuron protein isoform d | 14 | 0 | 0 | 14 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 16 | 0 | 0 | 16 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 25 | 0 | 0 | 25 |
Glutamate receptor 2 | 16 | 3 | 0 | 20 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 5 | 4 | 10 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 17 | 0 | 0 | 17 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 13 | 0 | 0 | 13 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
acetylcholinesterase | 16 | 0 | 0 | 16 |
aldehyde dehydrogenase 1 family, member A1 | 21 | 0 | 0 | 21 |
regulator of G-protein signaling 4 | 12 | 0 | 0 | 12 |
glucocerebrosidase | 5 | 0 | 0 | 5 |
alpha-galactosidase | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 isoform 1 | 12 | 0 | 0 | 12 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 11 | 0 | 0 | 11 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
huntingtin isoform 2 | 6 | 0 | 0 | 6 |
Membrane primary amine oxidase | 0 | 2 | 0 | 2 |
Prothrombin | 0 | 1 | 0 | 1 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Trypsin-2 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 1 | 0 | 1 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 7 | 0 | 7 |
Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 22 | 0 | 22 |
Sodium channel protein type 5 subunit alpha | 0 | 6 | 0 | 6 |
Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 12 | 0 | 0 | 12 |
RAR-related orphan receptor gamma | 25 | 0 | 0 | 25 |
GLI family zinc finger 3 | 24 | 0 | 0 | 24 |
nuclear receptor subfamily 1, group I, member 3 | 24 | 0 | 0 | 24 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 20 | 0 | 0 | 20 |
retinoic acid nuclear receptor alpha variant 1 | 24 | 0 | 0 | 24 |
retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
farnesoid X nuclear receptor | 15 | 0 | 0 | 15 |
pregnane X nuclear receptor | 21 | 0 | 0 | 21 |
cytochrome P450 2D6 | 23 | 0 | 0 | 23 |
peroxisome proliferator activated receptor gamma | 19 | 0 | 0 | 19 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 18 | 0 | 0 | 18 |
aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 12 | 0 | 0 | 12 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 15 | 0 | 0 | 15 |
thyroid hormone receptor beta isoform a | 9 | 0 | 0 | 9 |
potassium voltage-gated channel subfamily H member 2 isoform d | 13 | 0 | 0 | 13 |
heat shock protein beta-1 | 8 | 0 | 0 | 8 |
cytochrome P450 3A4 isoform 1 | 14 | 0 | 0 | 14 |
Gamma-aminobutyric acid receptor subunit pi | 14 | 2 | 1 | 17 |
Alpha-2A adrenergic receptor | 0 | 26 | 6 | 34 |
Gamma-aminobutyric acid receptor subunit beta-1 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit delta | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 14 | 3 | 1 | 18 |
Gamma-aminobutyric acid receptor subunit beta-3 | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit beta-2 | 14 | 2 | 1 | 17 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
GABA theta subunit | 14 | 2 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit epsilon | 14 | 2 | 1 | 17 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 8 | 0 | 0 | 8 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 18 | 0 | 0 | 18 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
DNA polymerase iota isoform a (long) | 14 | 0 | 0 | 14 |
DNA polymerase kappa isoform 1 | 8 | 0 | 0 | 8 |
muscarinic acetylcholine receptor M1 | 11 | 0 | 0 | 11 |
lethal factor (plasmid) | 9 | 0 | 0 | 9 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 6 | 0 | 6 |
Carbonic anhydrase 2 | 0 | 7 | 1 | 9 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Integrin beta-3 | 4 | 1 | 0 | 5 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 4 | 1 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 6 |
Adenosine receptor A1 | 0 | 5 | 0 | 6 |
Adenosine receptor A2a | 0 | 4 | 2 | 8 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 5 | 1 | 1 | 7 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 21 | 1 | 22 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 1 | 5 |
Chain A, Cruzipain | 4 | 0 | 0 | 4 |
SMAD family member 2 | 7 | 0 | 0 | 7 |
SMAD family member 3 | 7 | 0 | 0 | 7 |
caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
caspase-3 | 8 | 0 | 0 | 8 |
Caspase-7 | 4 | 0 | 0 | 4 |
vitamin D3 receptor isoform VDRA | 13 | 0 | 0 | 13 |
caspase-3 | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 14 | 0 | 18 |
Insulin receptor | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 3 | 0 | 3 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 2 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 6 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 3 |
Spike glycoprotein | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 9 | 0 | 0 | 9 |
Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 22 | 3 | 25 |
Procathepsin L | 0 | 0 | 2 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 10 | 0 | 10 |
Muscarinic acetylcholine receptor M2 | 0 | 19 | 4 | 24 |
Muscarinic acetylcholine receptor M4 | 0 | 16 | 3 | 20 |
Muscarinic acetylcholine receptor M1 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M5 | 0 | 15 | 2 | 18 |
Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 16 | 5 | 22 |
Alpha-2B adrenergic receptor | 0 | 20 | 3 | 25 |
Alpha-2C adrenergic receptor | 0 | 20 | 5 | 27 |
Muscarinic acetylcholine receptor M3 | 0 | 17 | 4 | 22 |
Sodium-dependent noradrenaline transporter | 0 | 13 | 0 | 13 |
Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
Histamine H2 receptor | 0 | 12 | 0 | 12 |
Alpha-1D adrenergic receptor | 0 | 18 | 3 | 22 |
5-hydroxytryptamine receptor 2A | 0 | 22 | 1 | 25 |
5-hydroxytryptamine receptor 2C | 0 | 23 | 2 | 25 |
Sodium-dependent serotonin transporter | 0 | 19 | 0 | 19 |
Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
Histamine H1 receptor | 0 | 14 | 3 | 19 |
D(3) dopamine receptor | 0 | 18 | 0 | 20 |
5-hydroxytryptamine receptor 2B | 0 | 24 | 2 | 26 |
Histamine H2 receptor | 12 | 2 | 0 | 16 |
5-hydroxytryptamine receptor 6 | 0 | 13 | 1 | 15 |
Spike glycoprotein | 20 | 0 | 2 | 22 |
Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
USP1 protein, partial | 13 | 0 | 0 | 13 |
chromobox protein homolog 1 | 18 | 0 | 0 | 18 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 8 | 4 | 13 |
Alpha-1B adrenergic receptor | 0 | 7 | 3 | 11 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 0 | 3 | 3 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
67.9K protein | 6 | 0 | 0 | 6 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
nuclear receptor ROR-gamma isoform 1 | 12 | 0 | 0 | 12 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 12 | 0 | 0 | 12 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
Ataxin-2 | 17 | 0 | 0 | 17 |
5-hydroxytryptamine receptor 3E | 0 | 5 | 1 | 6 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 3B | 0 | 5 | 1 | 6 |
Beta-2 adrenergic receptor | 0 | 5 | 1 | 6 |
Beta-1 adrenergic receptor | 0 | 3 | 1 | 4 |
Cytochrome P450 3A4 | 0 | 15 | 3 | 21 |
5-hydroxytryptamine receptor 1A | 0 | 8 | 1 | 9 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 0 | 11 |
Cytochrome P450 2D6 | 0 | 14 | 1 | 17 |
Angiotensin-converting enzyme | 0 | 7 | 0 | 7 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
D(2) dopamine receptor | 0 | 16 | 1 | 20 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 13 | 0 | 13 |
Alpha-1B adrenergic receptor | 0 | 16 | 4 | 20 |
D | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1A | 0 | 14 | 1 | 16 |
Alpha-2B adrenergic receptor | 0 | 13 | 4 | 17 |
D(1A) dopamine receptor | 0 | 10 | 1 | 12 |
Alpha-2C adrenergic receptor | 0 | 13 | 4 | 17 |
Alpha-2A adrenergic receptor | 0 | 13 | 4 | 17 |
Alpha-1D adrenergic receptor | 0 | 13 | 4 | 18 |
5-hydroxytryptamine receptor 1B | 0 | 12 | 0 | 12 |
5-hydroxytryptamine receptor 1D | 0 | 7 | 0 | 7 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2B | 0 | 9 | 1 | 10 |
5-hydroxytryptamine receptor 7 | 0 | 7 | 1 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 7 | 0 | 7 |
Alpha-1A adrenergic receptor | 0 | 17 | 5 | 22 |
5-hydroxytryptamine receptor 3A | 0 | 7 | 1 | 8 |
D(2) dopamine receptor | 0 | 10 | 1 | 11 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 4 | 0 | 5 | 4 | 9 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 8 | 0 | 8 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 9 | 0 | 10 |
Neutral alpha-glucosidase AB | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 3 | 2 | 7 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 3D | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 3B | 0 | 7 | 0 | 7 |
Heparanase | 0 | 0 | 1 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
Beta-1 adrenergic receptor | 0 | 2 | 2 | 5 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 4 |
D(3) dopamine receptor | 0 | 9 | 0 | 9 |
D(1B) dopamine receptor | 0 | 5 | 0 | 5 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Adenosine receptor A2b | 0 | 1 | 1 | 3 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 6 | 0 | 6 |
Delta-type opioid receptor | 0 | 10 | 2 | 15 |
Mu-type opioid receptor | 0 | 10 | 3 | 14 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Nischarin | 0 | 2 | 0 | 2 |
nonstructural protein 1 | 6 | 0 | 0 | 6 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Cytochrome P450 2B6 | 0 | 4 | 0 | 4 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 7 | 1 | 11 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 8 | 0 | 0 | 8 |
Luciferase | 11 | 0 | 0 | 11 |
ATAD5 protein, partial | 10 | 0 | 0 | 10 |
Fumarate hydratase | 8 | 0 | 0 | 8 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
G | 14 | 0 | 0 | 14 |
polyprotein | 8 | 0 | 0 | 8 |
bromodomain adjacent to zinc finger domain 2B | 8 | 0 | 0 | 8 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
D(1A) dopamine receptor | 9 | 0 | 0 | 9 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 2 precursor | 5 | 0 | 0 | 5 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
peripheral myelin protein 22 | 15 | 0 | 0 | 15 |
M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Interferon beta | 17 | 0 | 0 | 17 |
HLA class I histocompatibility antigen, B alpha chain | 14 | 0 | 0 | 14 |
Albumin | 0 | 0 | 3 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 0 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M5 | 0 | 8 | 0 | 8 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 0 | 5 |
Beta-1 adrenergic receptor | 0 | 3 | 1 | 5 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 7 | 0 | 9 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 5 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 0 | 3 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Calmodulin | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 14 | 0 | 0 | 14 |
D | 0 | 2 | 0 | 2 |
Histamine H4 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 5 | 1 | 7 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 14 | 0 | 0 | 14 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
Kappa-type opioid receptor | 0 | 6 | 3 | 11 |
Mu-type opioid receptor | 0 | 18 | 10 | 32 |
Delta-type opioid receptor | 0 | 18 | 8 | 30 |
Kappa-type opioid receptor | 0 | 16 | 8 | 29 |
Mu-type opioid receptor | 0 | 7 | 3 | 14 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 4 | 4 |
endonuclease IV | 6 | 0 | 0 | 6 |
glp-1 receptor, partial | 8 | 0 | 0 | 8 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 6 | 0 | 0 | 6 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 6 | 0 | 0 | 6 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 1 | 0 | 2 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 12 | 0 | 0 | 12 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
PPM1D protein | 5 | 0 | 0 | 5 |
cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Transthyretin | 0 | 2 | 1 | 6 |
NADH-ubiquinone oxidoreductase chain 4 | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
Glutamate receptor 1 | 1 | 3 | 0 | 5 |
Glutamate receptor 3 | 1 | 3 | 0 | 5 |
Glutamate receptor 4 | 1 | 3 | 0 | 5 |
Platelet-activating factor receptor | 1 | 0 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 4 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Hsf1 protein | 0 | 0 | 3 | 4 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Albumin | 0 | 3 | 4 | 7 |
Interleukin-8 | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 2 | 1 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 5 | 0 | 7 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostacyclin receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
Motilin receptor | 0 | 0 | 1 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 4 | 0 | 0 | 4 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Motilin receptor | 0 | 1 | 1 | 2 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
30S ribosomal protein S6 | 0 | 1 | 1 | 2 |
30S ribosomal protein S7 | 0 | 1 | 1 | 2 |
50S ribosomal protein L15 | 0 | 1 | 1 | 2 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
50S ribosomal protein L10 | 0 | 1 | 1 | 2 |
50S ribosomal protein L11 | 0 | 1 | 1 | 2 |
50S ribosomal protein L7/L12 | 0 | 1 | 1 | 2 |
50S ribosomal protein L19 | 0 | 1 | 1 | 2 |
50S ribosomal protein L1 | 0 | 1 | 1 | 2 |
50S ribosomal protein L20 | 0 | 1 | 1 | 2 |
50S ribosomal protein L27 | 0 | 1 | 1 | 2 |
50S ribosomal protein L28 | 0 | 1 | 1 | 2 |
50S ribosomal protein L29 | 0 | 1 | 1 | 2 |
50S ribosomal protein L31 | 0 | 1 | 1 | 2 |
50S ribosomal protein L31 type B | 0 | 1 | 1 | 2 |
50S ribosomal protein L32 | 0 | 1 | 1 | 2 |
50S ribosomal protein L33 | 0 | 1 | 1 | 2 |
50S ribosomal protein L34 | 0 | 1 | 1 | 2 |
50S ribosomal protein L35 | 0 | 1 | 1 | 2 |
50S ribosomal protein L36 | 0 | 1 | 1 | 2 |
30S ribosomal protein S10 | 0 | 1 | 1 | 2 |
30S ribosomal protein S11 | 0 | 1 | 1 | 2 |
30S ribosomal protein S12 | 0 | 1 | 1 | 2 |
30S ribosomal protein S13 | 0 | 1 | 1 | 2 |
30S ribosomal protein S16 | 0 | 1 | 1 | 2 |
30S ribosomal protein S18 | 0 | 1 | 1 | 2 |
30S ribosomal protein S19 | 0 | 1 | 1 | 2 |
30S ribosomal protein S20 | 0 | 1 | 1 | 2 |
30S ribosomal protein S2 | 0 | 1 | 1 | 2 |
30S ribosomal protein S3 | 0 | 1 | 1 | 2 |
30S ribosomal protein S4 | 0 | 1 | 1 | 2 |
30S ribosomal protein S5 | 0 | 1 | 1 | 2 |
30S ribosomal protein S8 | 0 | 1 | 1 | 2 |
30S ribosomal protein S9 | 0 | 1 | 1 | 2 |
50S ribosomal protein L13 | 0 | 1 | 1 | 2 |
50S ribosomal protein L14 | 0 | 1 | 1 | 2 |
50S ribosomal protein L16 | 0 | 1 | 1 | 2 |
50S ribosomal protein L23 | 0 | 1 | 1 | 2 |
30S ribosomal protein S15 | 0 | 1 | 1 | 2 |
50S ribosomal protein L17 | 0 | 1 | 1 | 2 |
50S ribosomal protein L21 | 0 | 1 | 1 | 2 |
50S ribosomal protein L30 | 0 | 1 | 1 | 2 |
50S ribosomal protein L6 | 0 | 1 | 1 | 2 |
30S ribosomal protein S14 | 0 | 1 | 1 | 2 |
30S ribosomal protein S17 | 0 | 1 | 1 | 2 |
30S ribosomal protein S1 | 0 | 1 | 1 | 2 |
50S ribosomal protein L18 | 0 | 1 | 1 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Chitinase B | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 1 | 2 |
50S ribosomal protein L3 | 0 | 1 | 1 | 2 |
50S ribosomal protein L24 | 0 | 1 | 1 | 2 |
50S ribosomal protein L4 | 0 | 1 | 1 | 2 |
50S ribosomal protein L22 | 0 | 1 | 1 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
50S ribosomal protein L5 | 0 | 1 | 1 | 2 |
30S ribosomal protein S21 | 0 | 1 | 1 | 2 |
50S ribosomal protein L25 | 0 | 1 | 1 | 2 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 4 | 1 | 5 |
50S ribosomal protein L36 2 | 0 | 1 | 1 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
Delta-type opioid receptor | 0 | 12 | 4 | 17 |
Mu-type opioid receptor | 0 | 12 | 5 | 20 |
Kappa-type opioid receptor | 0 | 8 | 4 | 13 |
Kappa-type opioid receptor | 0 | 10 | 1 | 12 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
pregnane X receptor | 5 | 0 | 0 | 5 |
Thrombopoietin | 4 | 0 | 0 | 4 |
urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
plasminogen precursor | 5 | 0 | 0 | 5 |
urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
Vpr | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
Aromatase | 0 | 3 | 0 | 3 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
ClpP | 4 | 0 | 0 | 4 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Ribonucleoside-diphosphate reductase large subunit | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 3 | 1 | 5 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 8 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 1 | 7 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 3 | 0 | 3 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 1 | 7 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 1 | 7 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 1 | 7 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 2 | 1 | 3 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
Caspase-1 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Parkin | 4 | 0 | 0 | 4 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 0 | 3 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 2 | 5 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 3 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 3 |
Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 2 | 1 | 3 |
Histamine H3 receptor | 0 | 0 | 1 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
Menin | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 2 | 0 | 2 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
histone-lysine N-methyltransferase NSD2 isoform 1 | 0 | 0 | 0 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase TEM | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 1 | 2 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 3 | 4 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 1 | 6 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 3 |
Adenosine receptor A1 | 0 | 5 | 1 | 8 |
Cholinesterase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 3 | 3 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Integrin beta | 0 | 0 | 1 | 1 |
Glycoprotein IIb | 0 | 0 | 1 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 7 | 1 | 8 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
Bile acid receptor | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Bifunctional cytochrome P450/NADPH--P450 reductase | 0 | 0 | 1 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Bombesin receptor subtype-3 | 0 | 0 | 1 | 1 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 2 | 0 | 2 |
MCOLN3 protein | 0 | 0 | 1 | 1 |
transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
Type II pantothenate kinase | 0 | 0 | 0 | 1 |
Type III pantothenate kinase | 0 | 0 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Protease | 0 | 3 | 0 | 3 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Prolyl 4-hydroxylase, beta polypeptide | 0 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
Gastric inhibitory polypeptide receptor | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 4 | 6 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |